042520.KQ - HansBiomed Corporation

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Currency in KRW

Valuation Measures

Market Cap (intraday) 5203.56B
Enterprise Value 3220.34B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.31
Price/Book (mrq)N/A
Enterprise Value/Revenue 33.58
Enterprise Value/EBITDA 617.53

Trading Information

Stock Price History

Beta (3Y Monthly) 0.24
52-Week Change 3N/A
S&P500 52-Week Change 32.12%
52 Week High 330,100.00
52 Week Low 321,500.00
50-Day Moving Average 329,050.00
200-Day Moving Average 329,050.00

Share Statistics

Avg Vol (3 month) 3203.59k
Avg Vol (10 day) 3195.09k
Shares Outstanding 58.95M
Float 7.22M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 8.31%
Operating Margin (ttm)17.36%

Management Effectiveness

Return on Assets (ttm)7.31%
Return on Equity (ttm)9.22%

Income Statement

Revenue (ttm)61.5B
Revenue Per Share (ttm)5,927.26
Quarterly Revenue Growth (yoy)37.70%
Gross Profit (ttm)27.28B
EBITDA 12.57B
Net Income Avi to Common (ttm)5.11B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)63.90%

Balance Sheet

Total Cash (mrq)4.86B
Total Cash Per Share (mrq)494.71
Total Debt (mrq)10B
Total Debt/Equity (mrq)13.77
Current Ratio (mrq)2.10
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)3.19B
Levered Free Cash Flow (ttm)-3.14B